Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,040 | 31,150 | 44,722 | 45,277 | 61,653 |
| Marketable Securities | 64,012 | 88,625 | 126,081 | 172,294 | 186,409 |
| Receivables | 346 | 431 | 686 | 484 | 597 |
| TOTAL | $123,068 | $132,935 | $184,361 | $231,550 | $256,573 |
| Non-Current Assets | |||||
| PPE Net | 1,764 | 1,899 | 1,513 | 1,099 | 1,145 |
| Investments And Advances | 83,944 | 90,992 | 33,602 | 12,242 | 0 |
| Intangibles | 6,917 | 6,935 | 6,954 | 6,973 | 6,992 |
| Other Non-Current Assets | 2,661 | 2,888 | 3,275 | 2,732 | 2,922 |
| TOTAL | $95,286 | $102,714 | $45,344 | $23,046 | $11,059 |
| Total Assets | $218,354 | $235,649 | $229,705 | $254,596 | $267,632 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,648 | 11,425 | 8,190 | 10,351 | 7,667 |
| Accrued Expenses | 15,160 | 8,744 | 7,263 | 8,701 | 9,154 |
| TOTAL | $27,320 | $22,829 | $18,258 | $21,938 | $19,789 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 34,334 | 32,703 | 34,270 | 34,670 | 27,638 |
| TOTAL | $34,701 | $33,070 | $34,637 | $35,037 | $28,005 |
| Total Liabilities | $62,021 | $55,899 | $52,895 | $56,975 | $47,794 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,836 | 70,795 | 70,679 | 66,693 | 66,683 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -769,305 | -740,044 | -710,475 | -682,315 | -654,680 |
| Other shareholders' equity | -1,129 | -1,111 | -354 | -897 | -1,465 |
| TOTAL | $156,333 | $179,750 | $176,810 | $197,621 | $219,838 |
| Total Liabilities And Equity | $218,354 | $235,649 | $229,705 | $254,596 | $267,632 |